Successful salvage therapy of intravenous cyclophosphamide for refractory polymyositis in an elderly patient: case report.
Dermatomyositis and polymyositis may affect children and adults and are now widely recognized as major causes of disability which, thanks to the introduction of immunosuppressive drugs, is often treatable, at least to some extent. Few data exist regarding polymyositis in elderly patients. We describe a case of refractory life-threatening polymyositis in an elderly patient, successfully treated with intravenous cyclophosphamide.
Pinto
A
A
Tuttolomondo
A
A
Di Raimondo
D
D
Di Gati
M
M
Di Sciacca
R
R
Fernandez
P
P
Licata
G
G
D000368:Aged; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007262:Infusions, Intravenous; D008297:Male; D017285:Polymyositis / Q000188:drug therapy*; D016879:Salvage Therapy; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous; D003520:Cyclophosphamide